ACADEMIC APPOINTMENTS, PROFESSIONAL POSITIONS, AND HONORS
Positions and Employment:
Predoctoral Intern, Veteran’s Administration Medical Center, Palo, Alto, California (1900 hours, APA approved), 9/79 to 9/80
Staff Psychologist, Napa State Hospital, Imola, California, 10/80 to 8/82
Neuropsychology Postdoctoral Fellow, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, 9/82 to 9/83
Instructor of Psychiatry, University of Colorado School of Medicine, Denver, Colorado, 9/83 to 7/84
Assistant Professor of Psychiatry, University of Colorado School of Medicine, 7/84 to 7/92
Coordinator, Cognitive Rehabilitation Program, University of Colorado Health Sciences Center, 9/85 to 12/88
Acting Director, Neuropsychology Laboratory, University of Colorado Health Sciences Center, 5/87 to 9/94
Assistant Professor of Neurology, University of Colorado School of Medicine, 11/90 to 12/92
Director, Neuropsychology Laboratory, University of Colorado Health Sciences Center, 9/88 to present
Associate Professor of Psychiatry, University of Colorado School of Medicine, 7/92 to present
Associate Professor of Neurology, University of Colorado School of Medicine, 12/92 to present
Neuropsychologist, Polytrauma Program, Veterans’ Affairs Medical Center, Denver, 2/07 to present
Other Experience and Professional Memberships:
Diplomate in Clinical Neuropsychology, American Board of Professional Psychology #5425
Licensed Psychologist, Colorado # 885
Editorial Board Member, Psychological Assessment, Archives of Clinical Neuropsychology,
Member, Scientific Advisory Committee, Rocky Mountain Regional Clinical Trials Node, (2000-2005)
Treasurer, National Academy of Neuropsychology, 1998-2000
Fellow, National Academy of Neuropsychology
President, Colorado Neuropsychological Society, 1994
Member, American Psychological Association
Member, International Neuropsychological Society
Phi Beta Kappa, 1975
Graduated University of Texas, 1975, with High Honors in Psychology
Awarded Four Year Honors Fellowship from University of Kansas Graduate School, 1975-1979
Co-Director of Course on Psychological and Neuropsychological Assessment for PGY II Psychiatry Residents, approximately 6-7 sessions per year, 2008 to present
Lecturer on traumatic brain injury and neuropsychological assessment to psychology interns at Denver VA Medical Center, 2007 to present
Supervisor of psychology interns on Traumatic Brain Injury rotation at Denver VA Medical Center, 2007 to present
Co-Director of Course on Psychological and Neuropsychological Assessment for PGY III Psychiatry Residents, approximately 6 sessions per year, 2003 to 2007
Guest lecturer on Neuropsychology and related topics for seminars and courses for residents in Neurology, Neurosurgery, Rheumatology, and trainees in Social Work, 1987 to present
Clinical work involves neuropsychological assessment and consultation with patients who have, or are being evaluated for, a wide range of psychiatric and neurological disorders.
Neuropsychologist, Polytrauma Program, Denver VA Medical Center, 2/07 to present
Neuropsychological evaluation and consultation for the Polytrauma Service, work on interdisciplinary TBI Team, provide TBI education, neuropsychological feedback, treatment and planning recommendations and compensatory strategies to patients, staff, and families.
Neuropsychologist, Neuropsychologiy Lab, Department of Psychiatry, 9/83 to present
Neuropsychological evaluation and consultation to treatment providers for patients in the community presenting with questions about neurological diagnosis, cognitive functioning, implications of neuropsychological impairments for treatment and everyday life.
SCHOLARSHIPS AND PUBLICATIONS
Selected Peer-Reviewed Publications:
1. Thompson, L.L., Riggs, P.D., Mikulich, S.K. & Crowley, T.J. (1996). Contribution of ADHD symptoms to substance problems and delinquency in conduct disordered adolescents. Journal of Abnormal Child Psychology, 24, 325-347.
2. Riggs, P.D., Thompson, L.L., Mikulich, S.M., Whitmore, E.A.& Crowley, T.J. (1996). An open trial of pemoline in drug-dependent delinquents with attention-deficit hyperactivity disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 35, 1018-1024.
3. Whitmore, E.A., Mikulich, S.K., Thompson, L.L., Riggs, P.D., Aarons, G.A. & Crowley, T.J. (1997). Influences on adolescent substance dependence: Conduct disorder, depression, attention deficit hyperactivity disorder, and gender. Drug and Alcohol Dependence, 47, 87-97.
4. Cullum, C.M. & Thompson, L.L. (1997). Neuropsychological diagnosis and outcome in mild traumatic brain injury. Applied Neuropsychology, 4, 6-15.
5. McSweeney, A.J., Becker, B.C., Naugle, R.I., Snow, L.M., and Thompson, L.L. (1998). Ethical issues related to the presence of third party observers in clinical neuropsychological evaluations. The Clinical Neuropsychologist, 12, 552-559.
6. Filley, C.M., Thompson, L.L., Sze, C-I, Simon, J.A., Paskavitz, J.F. & Kleinschmidt-DeMasters, B.K. (1999). White matter dementia in CADASIL. Journal of the Neurological Sciences, 163, 163-167.
7. Kongs, S.K., Thompson, L.L., Iverson, G.L. & Heaton, R.K. (2000). Wisconsin Card Sorting Test - 64 Card Version Professional Manual. Odessa, FL: Psychological Assessment Resources.
8. Thompson, L.L. (2001). Neuropsychological testing. In J.L. Jacobson & A.M.Jacobson (Eds.), Psychiatric secrets (2nd edition). Philadelphia: Hanley & Belfus, Inc.
9. Sapir, S., Pawlas, A.A., Ramig, L.O., Countryman, S., O’Brien, C., Hoehn, M.M., & Thompson, L.L. (2001). Voice and speech abnormalities in Parkinson disease: Relation to severity of motor impairment, duration of disease, medication, depression, gender, and age. Journal of Medical Speech-Language Pathology, 9, 213-226.
10. Ramig, L.O., Sapir, S., Countryman, S., Pawlas, A.A., O’Brien, C., Hoehn, M.M. & Thompson, L.L. (2001). Intensive voice treatment (LSVT) for individuals with Parkinson’s disease: a 2 year follow-up. Journal of Neurology, Neurosurgery and Psychiatry, 71, 493-8.
11. Thompson, L.L. (2002). Ethical issues in interpreting and explaining assessment results. In S. Bush & M. Drexler (Eds.), Ethical Issues in Clinical Neuropsychology, (pp 51-72). Lisse, Netherlands: Swets & Zeitlinger.
12. Thompson, L.L. (2003). Neuropsychological assessment of physicians whose competency to practice medicine is being questioned. In G. Prigatano & N. Pliskin (Eds.), Clinical Utility and Cost Effectiveness of Neuropsychological Services, (pp 373-392). Philadelphia: Psychology Press.
13. Freed, C.R., Leehey, M.A., Zawada, M., Bjugstad, K., Thompson, L., & Breeze, R.E. (2003). Do patients with Parkinson’s disease benefit from embryonic dopamine cell transplantation? Journal of Neurology, 250, III/44-III/46.
14. Benedict, R.H.B., Cox, D., Thompson, L.L., Foley, F., Weinstock-Guttman, B. & Munschauer, F. (2004). Reliable screening for neuropsychological impairment in multiple sclerosis. Multiple Sclerosis, 10, 675-678.
15. Thompson, L.L. (2005). Ethical challenges in neuropsychological research, part I. In S.S. Bush (ed.), A Casebook of Ethical Challenges in Neuropsychology (pp.201-208). New York: Psychology Press.
16. Crowley, T.J., Raymond, K.E., Mikulich-Gilbertson, S.K., Thompson, L.L. & Lejuez, C.W. (2006). A risk-taking “set” in a novel task among adolescents with serious conduct and substance problems. Journal of the American Academy of Child and Adolescent Psychiatry, 45, 175-183.
17. Thompson, L.L., Whitmore, E.A., Raymond, K.M. & Crowley, T.J. (2006). Measuring impulsivity in adolescents with serious substance and conduct problems. Assessment, 13, 3-15.
18. Banich, M.T., Crowley, T.J., Thompson, L.L., Jacobson, B.L., Liu, X., Raymond, K.M., & Claus, D. (2007). Brain activation during the Stroop task in adolescents with severe substance and conduct problems: a pilot study. Drug and Alcohol Dependence, 90, 175-182.
19. Riggs, P.D., Thompson, L.L., Tapert, S.F., Frascella, J., Mikulich-Gilbertson, S., Dalwani, M., Laudenslager, M., & Lohman, M. (2007). Advances in neurobiological research related to interventions in adolescents with substance use disorders: Research to practice. Drug and Alcohol Dependence, 91, 306-311.
20. Tanabe, J., Thompson, L., Banich, M., Claus, E., Dalwani, M., & Hutchison, K. (2007). Prefrontal activity is reduced in gambling and non-gambling substance users during decision-making. Human Brain Mapping, 28, 1276-1286.
21. Tanabe, J., Tregellas, J.R., Dalwani, M., Thompson, L., Owens, E., Crowley, T., & Banich, M. (2009). Medial orbitofrontal cortex gray matter is reduced in abstinent substance-dependent individuals. Biological Psychiatry, 65, 160-164.
22. Korinek, L.L., Thompson, L.L., McRae, C. & Korinek, E. (2009). Do Physicians referred for competency evaluations have underlying cognitive problems? Academic Medicine, 84, 1015-1021.
Grants and Contracts:
Contract with Veterans Affairs, Eastern Colorado Health Care System, .50 FTE, 2/07-present
Ongoing Research Support
NIH/NIDA R01-1DA027748 (Tanabe), 9/1/09-8/31/14, Neural Correlates of Avoidance Learning in Substance Abuse
This project seeks to understand mechanisms underlying negative motivational affective state I and negative reinforcement learning deficits in substance-dependent individuals with decision making/learning tasks and functional MRI.
NINDS/MRS Consortium R01-NS03652 (Navia, Tufts PI; Campbell, Colorado PI), 5/1/06-4/30/11, A Longitudinal Study of Cerebral and Neurocognitive Function in HIV-infected Persons with a History of Advanced Disease on HAART
The goal of this multi-site study is to compare and correlate neurocognitive functioning and aspects of magnetic resonance spectroscopy (MRS) over time in individuals with HIV.
NIH/NIDA 1 R21 DA024104-01A1 (Tanabe), 6/15/08-5/31/10, Frontal striatal activity during decision making in substance abuse
This project uses a neurocomputational model of decision making to investigate differential roles of the basal ganglia and orbitofrontal cortex in processing frequency and magnitude information in substance abusers.
HRSA 1D40HP08517 (Seymour), 8/1/07-7/31/10, UCD Integrated Psychology Internship
The objectives of this grant are to prepare psychology interns to practice in health care settings, particularly primary care health settings, where underserved, minority and other disadvantaged populations seek health and mental health care services.
Completed Research Support
NIH/NIDA 2 R01 DA009842-13 (Crowley), 9/5/06-6/30/09, Substance Dependent Adolescents: Imaging Risk-Taking
The objective of this research is to better understand whether substances diminish the capacity to inhibit behavior by altering brain processing of risky decisions, or do pre-existing, anatomically-based variations of brain processing produce risk-taking propensities, or both
NIH/NIDA 5 R37 DA 09842-10 (Crowley, PI), 9/1/95-6/30/05, MERIT: Method to Extend Research in Time Award Substance-Use & Conduct Disorder: Motility, Neuropsych
The major goals of this project were to examine with new procedures, and describe, neuropsychological function of adolescents with Conduct Disorder and Substance Dependence, in preparation for later imaging studies.
NIH/NIDA 13716-05 (Riggs, PI)), 9/30/00-8/31/05, Rocky Mountain Regional Clinical Trials Node
Conducted studies of behavioral, pharmacological, and integrated behavioral and pharmacological treatment inventions of therapeutic effect in rigorous, multi-site clinical trials to determine effectiveness across a broad range of community-based treatment settings and diversified patient populations.
National Heart, Lung, and Blood Institute R01 HL075366 (Aloia), 3/8/07-6/30/08, Subcortical Hyperintensities in Sleep Apnea Syndrome
The goal of this study is to measure white matter hyperintensities using a semi-automated technique using data from the Cardiovascular Health Study to evaluate the relationship between endothelial function and white matter disease in patients with sleep apnea.
Grant awarded by the Institute for Research on Pathological Gambling and Related Disorders in the Harvard Medical School, Division on Addictions (Tanabe, PI), 7/01/03-6/30/05, Functional MRI of Decision-making in Substance Abuse and Pathological Gambling
Role: Co-Principal Investigator
Conducted study of the neural activation patterns seen in substance abusers with pathological gambling compared to substance abusers with no gambling problems, and community controls.